Position in NVO
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$707,258
+$138,442 QoQ
Shares Held
14,753
-4.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#614
of 1,348 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CENTRAL BANK & TRUST CO holds $18,304,852 across 8 Drug Manufacturers - General names. NVO ranks #7 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
16,134 | $5,842,444 | |
| 2 | MRK |
Merck & Co., Inc.
|
29,437 | $3,782,654 | |
| 3 | ABBV |
AbbVie Inc.
|
11,017 | $2,772,317 | |
| 4 | LLY |
ELI LILLY & Co
|
2,198 | $2,636,347 | |
| 5 | JNJ |
Johnson & Johnson
|
5,577 | $1,416,390 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
5,709 | $721,275 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
14,753 | $707,258 | |
| 8 | PFE |
Pfizer Inc
|
17,698 | $426,167 |
All Filings in NVO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $707,258 | 14,753 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $568,816 | 15,478 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $674,312 | 13,253 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $812,318 | 14,639 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $1,156,637 | 16,758 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $1,441,227 | 20,755 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $2,330,023 | 27,087 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $3,771,899 | 31,678 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $70,656 | 495 | Shares | Sole | 2024-07-19 | |
| No filing history on record for this holder in this stock. | ||||||